Accessibility Menu
PD-Rx Pharmaceuticals logo

PD-Rx Pharmaceuticals(OTC) PDRX

Market Cap$5.18MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1992)+265%
5 Year+23%
1 Year+39%
1 Month+0%
$3.35
+0%
+0.00Today
PD-Rx Pharmaceuticals last closing stock price
MetricPriceDate
Last closeUSD 3.352026-07-20
PD-Rx Pharmaceuticals stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 3.352026-05-12
1 month+0%USD 3.352026-05-12
3 month+0%USD 3.352026-04-10
Year to date+15.52%USD 2.902025-12-22
1 year+39%USD 2.412025-06-05
3 year-44.17%USD 6.002023-07-18
5 year+23.16%USD 2.722021-07-21
Since inception+264.65%USD 0.921992-01-24

PD-Rx Pharmaceuticals Financials at a Glance

Market Cap

$5.18MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

98883.02 (High)

Price

$3.35

Volume

20

Open

$3.35

Previous Close

$3.35

Daily Range

$3.35 - $3.35

52-Week Range

$2.41 - $3.35

Estimated Earnings Date

N/A

PDRX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About PD-Rx Pharmaceuticals

PD-Rx Pharmaceuticals, Inc. specializes in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States. The company offers a diverse range of medications and services, catering to various healthcare needs.

Products and Services
  • Prepackaged medications including creams, ointments, and liquids
  • Dispensing platform for tracking prescriptions and printing labels
  • Comprehensive physician dispensing services across multiple specialties
Growth Outlook
  • Strong demand for repackaged pharmaceuticals in the healthcare sector
  • Expansion of services to governmental and commercial markets
  • Innovative technology solutions enhancing operational efficiency
Financial Highlights
  • Market capitalization of approximately $5.75 million
  • Current ratio of 6.34 indicates strong liquidity position
  • Price-to-sales ratio of 0.31 suggests potential undervaluation
PD-Rx Pharmaceuticals, Inc. has established itself as a key player in the medical distribution industry, focusing on repackaged pharmaceutical products. The company’s diverse offerings, including a robust dispensing platform and specialized physician services, position it well to meet the evolving needs of the healthcare market. The growth outlook remains positive, driven by increasing demand for repackaged medications and the expansion of services into governmental and commercial sectors. The innovative technology solutions being implemented are expected to enhance operational efficiency, further solidifying the company's market position. Financially, PD-Rx Pharmaceuticals demonstrates a solid liquidity profile, as indicated by a current ratio of 6.34, which suggests the ability to cover short-term obligations effectively. The market capitalization of approximately $5.75 million and a price-to-sales ratio of 0.31 may indicate potential undervaluation, attracting interest from investors looking for opportunities in the healthcare sector. Overall, PD-Rx Pharmaceuticals, Inc. presents a compelling case for consideration in the medical distribution industry.
AI Generated • Jul 16, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

CEO

Robert D. Holsey, PhD

Website

www.pdrx.com

Headquarters

Oklahoma City, OK 73127, US

PDRX Financials

Key Financial Metrics (TTM)

Gross Margin

29.61%

Operating Margin

-2.60%

Net Income Margin

-1.40%

Return on Equity

-2.48%

Return on Capital

-4.66%

Return on Assets

-2.15%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.18MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.54M

Volume

20

Avg. Volume

51.936

Financials (TTM)

Gross Profit

$5.43M

Operating Income

-$477.42K

EBITDA

-$327.97K

Operating Cash Flow

$765.03K

Capital Expenditure

-$2.44K

Free Cash Flow

$762.59K

Cash & ST Invst.

$6.17M

Total Debt

$0.00

PD-Rx Pharmaceuticals Performance Analysis

PD-Rx Pharmaceuticals annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30USD 28,715,224N/A
20232023-06-30USD 21,271,614-25.9%
20242024-06-30USD 18,946,373-10.9%
20252025-06-30USD 18,348,667-3.2%
PD-Rx Pharmaceuticals annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30USD 1.84N/A
20232023-06-30USD -0.06N/A
20242024-06-30USD -0.46668.6%
20252025-06-30USD -0.16-65.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

$5.18MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CPIVFCaptiva Verde Wellness Corp.
$0.02+0.00%
RMSLREMSleep Holdings, Inc.
$0.00-9.09%
FZMDFuse Medical, Inc.
$0.02+0.00%
KOSKMetawells Oil & Gas Inc.
$0.00-29.64%

Trending Stocks

Symbol / CompanyPricePrice Chg
MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares
$19.63-0.20%
NOKNokia
$8.41-0.06%
SKHYSK Hynix
$126.79-0.03%
TQQQProShares Trust - ProShares UltraPro Qqq
$57.75-0.06%

Questions About PDRX

What is the current price of PD-Rx Pharmaceuticals?

PD-Rx Pharmaceuticals is trading at $3.35 per share.

What is the 52-week range for PD-Rx Pharmaceuticals?

Over the past 52 weeks, PD-Rx Pharmaceuticals has traded between $2.41 and $3.35.

How much debt does PD-Rx Pharmaceuticals have?

As of the most recent reporting period, PD-Rx Pharmaceuticals reported total debt of $0.00.

How much cash does PD-Rx Pharmaceuticals have on hand?

PD-Rx Pharmaceuticals reported $6.17M in cash and cash equivalents in its most recent financial results.

What is PD-Rx Pharmaceuticals’s dividend yield?

PD-Rx Pharmaceuticals does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services